Search Results 191-200 of 11357 for ���������������������������:za33���24������ ������������������������ ������
Rochester, Minnesota: 24-010877. NCT ID: NCT06873802. Sponsor Protocol Number: 24-010877. About this study. The purpose of this study is to demonstrate that ZTE ...
Myocardial infarction, Unstable angina, transient ischemic events, or stroke within 24 weeks of screening. 3. Alcohol Use Disorder Identification Test ...
The purpose of this study is to evaluate the effectiveness, safety, tolerability, and PK of INCB000928 over a 24-week treatment period followed by a 52-week ...
Jacksonville, Florida: 24-009952; Rochester, Minnesota: 24-009952; Scottsdale/Phoenix, Arizona: 24-009952. NCT ID: NCT06395519. Sponsor Protocol Number: ETX ...
Retreatment of multiple myeloma with previously refractory drugs. Blood Adv. 2024 Dec 24; 8(24):6321-6328. View PubMed; Rajkumar SV, Mateos MV, Schaeffer M, Lin ...
Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients ...
The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.